Impact of Gender-Affirming Hormone Therapy on Kidney Function Examined

WEDNESDAY, Aug. 17, 2022 -- Gender-affirming hormone therapy (GAHT) is associated with increased serum creatinine in transgender men, but not in transgender women, according to a systematic review and meta-analysis published online Aug. 16 in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news